Revlimid Advertiser Profile


Revlimid
Myeloma Prescription Drug
86 Morris Avenue, Summit, NJ US 07901
(908) 673-9000

Revlimid is part of Celgene Corporation. They spent under $100 million on advertising in digital and print in the last year. They invest in premium ad units and advertised on under 50 different Media Properties in the last year across multiple Media formats. Revlimid last advertised a new product in June, 2018.

We have 15 people on file in marketing roles at Revlimid, and 2 at their agencies.

Summary


Revlimid is part of Celgene Corporation. They spent under $100 million on advertising in digital and print in the last year. They invest in premium ad units and advertised on under 50 different Media Properties in the last year across multiple Media formats. Revlimid last advertised a new product in June, 2018.

We have 15 people on file in marketing roles at Revlimid, and 2 at their agencies.

MediaRadar helps advertising sales and agency business development teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.

We have identified 17 decision makers for you to contact at Revlimid, including Executives, Strategists, Media Buyers and Agency contacts.


Gail S.
Executive Director and Global Brand Lead, Otezla

David F.
Senior Manager

Elizabeth V.
Associate Director of US Marketing, Digital and Patient Strategy Lead, Lymphoma and Myeloid

Key Contacts


MediaRadar helps advertising sales and agency business development teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.

We have identified 17 decision makers for you to contact at Revlimid, including Executives, Strategists, Media Buyers and Agency contacts.


Gail S.
Executive Director and Global Brand Lead, Otezla

David F.
Senior Manager

Elizabeth V.
Associate Director of US Marketing, Digital and Patient Strategy Lead, Lymphoma and Myeloid

MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Revlimid and its subsidiaries.
Display
Display
Last ran on Journal Of Oncology Navigation And Survivorship on 6/12/2019.
Print
Print
Last ran on Oncology Times in the 06/2019 issue.
Display
Display
Last ran on Oncology Online on 3/12/2019.
Display
Display
Last ran on Journal Of Oncology Navigation And Survivorship on 6/12/2019.
Print
Print
Last ran on Oncology Times in the 06/2019 issue.
Display
Display
Last ran on Oncology Online on 3/12/2019.

Recent Ad Creative


MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Revlimid and its subsidiaries.
Display
Display
Last ran on Journal Of Oncology Navigation And Survivorship on 6/12/2019.
Print
Print
Last ran on Oncology Times in the 06/2019 issue.
Display
Display
Last ran on Oncology Online on 3/12/2019.
Display
Display
Last ran on Journal Of Oncology Navigation And Survivorship on 6/12/2019.
Print
Print
Last ran on Oncology Times in the 06/2019 issue.
Display
Display
Last ran on Oncology Online on 3/12/2019.

MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Revlimid Advertising Spend:
UNDER $100 Million
Decreased Spending YoY

Media Spend


MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Revlimid Advertising Spend:
UNDER $100 Million
Decreased Spending YoY

MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 22,130 new product launches overall.
Use MediaRadar to stay current on new product launches for Revlimid.

New Product Launches


MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 22,130 new product launches overall.
Use MediaRadar to stay current on new product launches for Revlimid.